Amphotericin B: current understanding of mechanisms of action.

Feb 1, 1987·Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology·C A HitchcockN J Russell

In vitro activity of systemic antifungal agents against Malassezia furfur.

Jun 1, 1987·Antimicrobial Agents and Chemotherapy·M J MarconW J Buesching

Toxicity and induction of resistance to Listeria monocytogenes infection by amphotericin B in inbred strains of mice.

Nov 1, 1986·Infection and Immunity·J BrajtburgG Medoff

Parallel inheritance of tissue catalase activity and immunostimulatory action of amphotericin B in inbred mouse strains

Mar 1, 1987·Cellular Immunology·S H SteinK D Little

Catheter-associated fungemia caused by Fusarium chlamydosporum in a patient with lymphocytic lymphoma.

Apr 1, 1985·Journal of Clinical Microbiology·T E KiehnD Armstrong

Fatal disseminated candidiasis due to amphotericin-B-resistant Candida guilliermondii

Jan 1, 1985·Annals of Internal Medicine·J D DickR Saral

Involvement of oxidative damage in erythrocyte lysis induced by amphotericin B.

Feb 1, 1985·Antimicrobial Agents and Chemotherapy·J BrajtburgG Medoff

Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism)

Jan 1, 1972·Proceedings of the National Academy of Sciences of the United States of America·G MedoffP Venkov

Sterols from polyene-resistant mutants of Candida albicans

Nov 1, 1972·Journal of General Microbiology·J M Hamilton-Miller

The development of resistance by candida species to polyene antibiotics in vitro

Nov 1, 1971·Journal of Medical Microbiology·M A Athar, H I Winner

Stimulatory, permeabilizing, and toxic effects of amphotericin B on L cells.

Dec 1, 1984·Antimicrobial Agents and Chemotherapy·J BrajtburgG Medoff

Polyene toxicity in renal medulla: injury mediated by transport activity

Apr 6, 1984·Science·M BrezisF H Epstein

Haemolytic activity of aromatic heptaenes. A group of polyene macrolide antifungal antibiotics

Jan 1, 1984·Biochemical Pharmacology·B CybulskaC M Gary-Bobo

Differences in the interaction of the polyene antibiotic amphotericin B with cholesterol- or ergosterol-containing phospholipid vesicles. A circular dichroism and permeability study

Jun 7, 1983·Biochemistry·A Vertut-CroquinC Gary-Bobo

Phenotypic resistance to miconazole and amphotericin B in Candida albicans

Apr 1, 1980·Journal of General Microbiology·E F GaleF Wayman

Leukoencephalopathy in patients treated with amphotericin B methyl ester

Aug 1, 1982·The Journal of Infectious Diseases·W G EllisS L Nielsen

Incidence of polyene-resistant yeasts recovered from clinical specimens.

Jul 1, 1980·Antimicrobial Agents and Chemotherapy·J D DickR Saral

Application of differential spectra in the ultraviolet-visible region to study the formation of amphotericin B-sterol complexes

Nov 4, 1980·Biochimica Et Biophysica Acta·I GrudaG Medoff

DEVELOPMENT OF RESISTANCE TO POLYENE ANTIBIOTICS IN CANDIDA ALBICANS.

Jun 1, 1965·Journal of Bacteriology·E K HEBEKA, M SOLOTOROVSKY

❮ Previous

Next ❯

Citations

Effect of amphotericin B on the lipids of yeast cells of Sporothrix schenckii

Jan 1, 1996·Mycopathologia·J S Hamdan, A K Casali

Proceedings of the American Society of Pediatric Nephrology 1993 Education Symposium, Washington, D.C., 4 May, 1993

Oct 1, 1994·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association

Effect of amphotericin B on the lipids of five different strains of Cryptococcus neoformans

Nov 1, 1994·Mycopathologia·S P Franzot, J S Hamdan

Discrepancies between MIC and MLC values of amphotericin B against isolates of Aspergillus species

Dec 1, 1994·Mycopathologia·A L ColomboM G Rinaldi

Emergence of Candida krusei infections after therapy of oropharyngeal candidiasis with fluconazole

Jul 1, 1991·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M AkovaD Gür

Functional consequences of oxidative membrane damage

Oct 26, 2005·The Journal of Membrane Biology·G Stark

Amphotericin B

Apr 12, 2005·Applied Microbiology and Biotechnology·A LemkeO Kayser

Amphotericin B-gum arabic conjugates: synthesis, toxicity, bioavailability, and activities against Leishmania and fungi

Mar 21, 2007·Pharmaceutical Research·K K NishiA Jayakrishnan

Emerging role of lipids of Candida albicans, a pathogenic dimorphic yeast

Jul 9, 1992·Biochimica Et Biophysica Acta·P MishraR Prasad

A study of patients' experiences of side-effects associated with chemotherapy: pilot stage report

Dec 1, 1995·International Journal of Nursing Studies·J SitziaL Sobrido

The role of amphotericin B amino group basicity in its antifungal action. A theoretical approach

Apr 1, 1994·Biophysical Chemistry·M BagińskiE Borowski

Activation of cultured astrocytes by amphotericin B: stimulation of NO and cytokines production and changes in neurotrophic factors production

Jun 4, 2013·Neurochemistry International·Akiko Motoyoshi-YamashiroYoichi Nakamura

Molecular dynamics simulation of the structure of dimyristoylphosphatidylcholine bilayers with cholesterol, ergosterol, and lanosterol

Mar 22, 2001·Biophysical Journal·A M Smondyrev, M L Berkowitz

Effects of oxygenated sterol on phospholipid bilayer properties: a molecular dynamics simulation

Aug 24, 2001·Chemistry and Physics of Lipids·A M Smondyrev, M L Berkowitz

Conformational analysis of Amphotericin B

Apr 22, 1997·Biophysical Chemistry·M BaginskiE Borowski

Effects of amphotericin B and ketoconazole on mouse oocyte maturation: implications on the role of meiosis-activating sterol

Oct 12, 2000·Molecular and Cellular Endocrinology·Z LuC Y Andersen

A post-PKS oxidation of the amphotericin B skeleton predicted to be critical for channel formation is not required for potent antifungal activity.

Oct 25, 2007·Journal of the American Chemical Society·Daniel S PalaciosMartin D Burke

Pretreatment with an ethanolic extract of Taiwanofungus camphoratus (Antrodia camphorata) enhances the cytotoxic effects of amphotericin B

Sep 9, 2011·Journal of Agricultural and Food Chemistry·Ling-Yi ChenChing-Hua Su

Amphotericin B dimers with bisamide linkage bearing powerful membrane-permeabilizing activity

Jun 7, 2002·Organic Letters·Nahoko YamajiMichio Murata

Amphotericin B as a potential probe of the physical state of vesicle membranes

Oct 8, 2004·Organic Letters·Andreas ZumbuehlErick M Carreira

Effect of amphotericin B on the metabolic profiles of Candida albicans

May 16, 2013·Journal of Proteome Research·Yingying CaoYuanying Jiang

The vacuole-targeting fungicidal activity of amphotericin B against the pathogenic fungus Candida albicans and its enhancement by allicin

Oct 31, 2009·The Journal of Antibiotics·Hasibagan BorjihanToshio Tanaka

Enhancement effect of N-methyl-N″-dodecylguanidine on the vacuole-targeting fungicidal activity of amphotericin B against the pathogenic fungus Candida albicans

Apr 28, 2011·The Journal of Antibiotics·Masahiro YutaniToshio Tanaka

The role of carbohydrates in biologically active natural products

Apr 1, 1997·Natural Product Reports·A C Weymouth-Wilson

Synthesis-enabled functional group deletions reveal key underpinnings of amphotericin B ion channel and antifungal activities

Mar 4, 2011·Proceedings of the National Academy of Sciences of the United States of America·Daniel S PalaciosMartin D Burke

Efficacy evaluation of a novel submicron amphotericin B emulsion in murine candidiasis

Jan 1, 1993·Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology·M Y LevyS Benita

Cytokines in mice treated with amphotericin B-intralipid

May 6, 2004·Medical Mycology·Y ShadkchanE Segal

Drs2p-related P-type ATPases Dnf1p and Dnf2p are required for phospholipid translocation across the yeast plasma membrane and serve a role in endocytosis

Mar 13, 2003·Molecular Biology of the Cell·Thomas PomorskiJoost C M Holthuis

Ability of teicoplanin and vancomycin to induce contraction of, and histamine release from, pulmonary tissue of humans, monkeys and guinea pigs

Mar 17, 2001·The Journal of Antimicrobial Chemotherapy·T NabeS Kohno

Characterization of the inhibitory effect of voriconazole on the fungicidal activity of amphotericin B against Candida albicans in an in vitro kinetic model

Apr 15, 2008·The Journal of Antimicrobial Chemotherapy·Anders LignellJan Sjölin

Amphotericin B nephrotoxicity in children

Jun 26, 2004·Journal of Pediatric Hematology/oncology·Ran D Goldman, Gideon Koren

Successful topical application of a new antifungal agent, micafungin, in the treatment of refractory fungal corneal ulcers: report of three cases and literature review

Jul 15, 2005·Cornea·Yukihiro MatsumotoKazuo Tsubota

Alteration of cell wall composition leads to amphotericin B resistance in Aspergillus flavus

Dec 28, 1999·Microbiology and Immunology·K SeoY Ohnishi

Menadione-catalyzed luminol chemiluminescent assay for the viability of Escherichia coli ATCC 25922

Jan 17, 2002·Microbiology and Immunology·S Yamashoji, M Takeda

Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani.

Nov 30, 2011·Antimicrobial Agents and Chemotherapy·Bidyut PurkaitPradeep Das

Inhibition of amphotericin B (Fungizone) toxicity to cells by egg lecithin-glycocholic acid mixed micelles.

Dec 1, 1990·Antimicrobial Agents and Chemotherapy·J BrajtburgG Medoff

Amphotericin B: delivery systems.

Mar 1, 1990·Antimicrobial Agents and Chemotherapy·J BrajtburgG Medoff

Comparative pharmacokinetics of amphotericin B after administration of a novel colloidal delivery system, ABCD, and a conventional formulation to rats.

Jun 1, 1991·Antimicrobial Agents and Chemotherapy·R M FieldingL S Guo

Lipid complexing decreases amphotericin B inflammatory activation of human neutrophils compared with that of a desoxycholate-suspended preparation of amphotericin B (Fungizone).

Jan 1, 1992·Antimicrobial Agents and Chemotherapy·G W SullivanG L Mandell

Influence of phospholipid/amphotericin B ratio and phospholipid type on in vitro renal cell toxicities and fungicidal activities of lipid-associated amphotericin B formulations.

Feb 1, 1992·Antimicrobial Agents and Chemotherapy·V JolyP Yeni

Pentoxifylline modulates activation of human neutrophils by amphotericin B in vitro.

Feb 1, 1992·Antimicrobial Agents and Chemotherapy·G W SullivanG L Mandell

Susceptibilities of serial Cryptococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole.

Jun 1, 1993·Antimicrobial Agents and Chemotherapy·A CasadevallM G Rinaldi

The endocytic process in CHO cells, a toxic pathway of the polyene antibiotic amphotericin B.

Oct 1, 1994·Antimicrobial Agents and Chemotherapy·A Vertut-DoïJ Bolard

Growth of Cryptococcus neoformans in presence of L-dopa decreases its susceptibility to amphotericin B.

Nov 1, 1994·Antimicrobial Agents and Chemotherapy·Y Wang, A Casadevall

Physicochemical cell damage in relation to lethal amphotericin B action.

Feb 1, 1994·Antimicrobial Agents and Chemotherapy·W H Beggs

Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B.

Mar 1, 1994·Antimicrobial Agents and Chemotherapy·J MukherjeeA Casadevall

Effect of ketoconazole on lethal action of amphotericin B on Leishmania mexicana promastigotes.

May 1, 1994·Antimicrobial Agents and Chemotherapy·H RamosB E Cohen

Synergism between the antifungal agents amphotericin B and alkyl glycerol ethers.

Jul 1, 1994·Antimicrobial Agents and Chemotherapy·M P HaynesR A Pieringer

Sterol compositions and susceptibilities to amphotericin B of environmental Cryptococcus neoformans isolates are changed by murine passage.

Sep 1, 1995·Antimicrobial Agents and Chemotherapy·B CurrieM A Ghannoum

Amphotericin B resistance and membrane fluidity in Kluyveromyces lactis strains.

Jun 20, 2000·Antimicrobial Agents and Chemotherapy·M YounsiJ Coulon

❮ Previous

Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.